Aberrant activation of the Wnt/β-
catenin has been shown to promote progression in various
cancers, including
ovarian cancer. However, the molecular mechanisms involved in Wnt/β-
catenin activation are not well elucidated. In the work, we identify that R-spondin 1 is an upstream regulator in Wnt/β-
catenin pathway to promote growth, survival and migration in
ovarian cancer cells. We observe the upregulation of transcript and
protein levels of R-spondin 1 in
ovarian cancer cell lines and tissues compared to normal counterparts. R-spondin 1 upregulation via genetic (overexpression) and pharmacological (
recombinant protein) approaches facilitates growth and migration of normal ovarian cells. R-spondin 1 downregulation via
siRNA knockdown decreases proliferation and migration, and induces apoptosis in
ovarian cancer cells. In addition, recombinant R-spondin 1 protects
ovarian cancer cell against
chemotherapy whereas R-spondin 1 knockdown sensitizes
ovarian cancer cell response to
chemotherapy. Importantly, increased β-
catenin activities and
mRNA expression levels of Wnt/β-
catenin-targeted genes are detected in normal ovarian cells overexpressing R-spondin 1. In contrast, R-spondin 1 inhibition suppresses Wnt/β-
catenin signaling in
ovarian cancer cells. We further identify that R-spondin 1 regulates
ovarian cancer biological activities via activating Wnt/β-
catenin. Our work is the first to highlight the critical roles of R-spondin 1 in
ovarian cancer progression and chemoresistance. Our work also provides a proper understanding on the regulation of Wnt/β-
catenin pathway in
ovarian cancer.